Good to know

You might have heard about a new medicine that’s just been approved to treat migraine. Here’s what you need to know.

5 common questions about the supplement that may be useful for ALS, Parkinson's and Alzheimers.

Find out about what it means to order and receive temperature-controlled medicines.

An easy to understand guide on how alectinib works.

A closer look at the function and efficicacy of niraparib as a maintenace treatment.

There are a number of medicines available for melanoma patients. In this article we examine one newer medicine and discuss it's efficacy and use. 

 

The European Medicines Agency has recently approved Niraparib (Zejula) for use in the European Union as a treatment for women struggling with a specific type of advanced ovarian cancer known as high-grade serous epithelial ovarian cancer, which includes cancers that affect the peritoneum and/or the fallopian tubes.

 

When a new medicine gets approved for use and for sale in a specific region, it’s usually given a brand name by the pharmaceutical company who discovered or developed it.

In 2015, an estimated 221,200 people in the U.S. will be diagnosed with lung cancer, which is 13 percent of all cancer diagnoses.

We talk to Sera, our Medicines Sourcing Manager about why drug delays happen...

Why every little package is a big deal

How effective is alectinib (Alecensa)? The latest news and updates